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Mutation of surface residues to charged amino acids
increases resistance to aggregation and can enable
reversible unfolding. We have developed a protocol
using the Rosetta computational design package
that ‘‘supercharges’’ proteins while considering the
energetic implications of each mutation. Using a ho-
mology model, a single-chain variable fragment anti-
body was designed that has a markedly enhanced
resistance to thermal inactivation and displays an un-
anticipated z30-fold improvement in affinity. Such
supercharged antibodies should prove useful for
assays in resource-limited settings and for devel-
oping reagents with improved shelf lives.
INTRODUCTION
Increasing the net charge of a polypeptide chain enhances solu-
bility and causes intermolecular repulsion in the unfolded state,
which in turn disfavors aggregation (Simeonov et al., 2011;
Fink, 1998). Single-chain FV antibody fragments (scFVs) are
useful reagents, but they tend to aggregate both in vivo and
in vitro, particularly at increased temperatures. Thus, they must
generally be refrigerated for storage, limiting their utility. David
Liu’s research group (Lawrence et al., 2007) previously demon-
strated that substitution of multiple surface residues with
charged amino acids (‘‘supercharging’’) markedly increases
resistance to thermally-induced aggregation in GFP, enabling
reversible unfolding and thus the recovery of fluorescence after
incubation at high temperatures. In this approach, residues
were selected for substitution with positively- (Arg, Lys) or nega-
tively-charged (Glu, Asp) amino acids based on solvent accessi-
bility as determined by the AvNAPSA algorithm (average number
of neighboring atoms per side-chain atom). A low AvNAPSA
score indicates that a given residue has few nearby nonselfChemistry & Biology 19,atoms and is thus likely to be solvent-exposed and amenable
to substitution (Lawrence et al., 2007).
However, when applied to a binding protein (streptavidin)
and an enzyme (glutathione S-transferase) this approach con-
ferred thermal resistance but diminished function (Lawrence
et al., 2007). In the current work, we have developed a protocol
using the Rosetta macromolecular modeling suite that con-
siders the energetic consequences of such substitutions with
the goal of predicting supercharging mutations in antibody
fragments that avoided the introduction of unfavorable con-
formations or interactions, avoided the removal of existing,
favorable interactions, and in many cases, introduced new,
favorable interactions. Experimental validation of these predic-
tions with the anti-MS2 scFV antibody fragment as a model
revealed that substitution of up to 14 residues with arginine
or lysine resulted in marked resistance to thermal denaturation
while retaining or improving antigen-binding activity. The use of
Rosetta protein design methods for the engineering of highly
stable scFVs represents a generalizable approach to address
the inherent propensity of single chain antibody fragments to
aggregate, especially at elevated temperatures (Jung and
Plu¨ckthun, 1997).RESULTS AND DISCUSSION
Homology Modeling of an Anti-MS2 Antibody
‘‘Ruggedizing’’ antibodies to remain functional over longer
periods of time under a variety of environmental conditions has
important implications for clinical and sensing applications.
The bacteriophage MS2 is frequently used as a viral stimulant
(McBride et al., 2003), and anti-MS2 coat protein antibodies
are frequently used to prototype biosensor systems (Thomas
et al., 2004). Unfortunately, no anti-MS2 antibody crystal struc-
tures exist to guide the placement of charged residues. Given
that many antibodies lack structures, the success of homology
modeling for supercharging would be particularly important for
future design efforts.449–455, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 449
Figure 1. Ten Homology Models of the Anti-MS2 scFV Overlaid with
Source PDBs Indicated for Grafted Regions
See also Table S1.
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Designing Supercharged, Thermoresistant AntibodiesWe used the RosettaAntibody FV homology modeling server
(Sircar et al., 2009) to create a series of structural models of
the anti-MS2 scFV. This process began by finding antibody
‘‘pieces’’ of known structure that had high sequence homology
to the anti-MS2 scFV. The most homologous VL and VH frame-
works (from Protein Data Bank [PDB] 1QKZ and 2A77) and L1,
L2, L3, H1, and H2 loops (1DLF, 1N4X, 1T66, 1H3P, and 1HIL)
were culled from the RosettaAntibody database (Sivasubrama-
nian et al., 2009). Sequence substitutions between the anti-
MS2 antibody and the matching pieces were reconciled by
modeling in the anti-MS2 antibody residues. The modeled loops
were then grafted onto the modeled frameworks, and the overall
homology model was further developed by identifying multiple,
low energy conformations of the H3 loop. As loop conformations
were explored, the VL-VH orientation and other complementarity
determining region (CDR) conformations were permitted to
change as needed. The 11 residue H3 loop of the anti-MS2
scFV is particularly important for ligand-binding; the nearest
sequence in the database (2DBL) had 70% identity but a different
loop length. Fortunately, loops in this size range have previously
been modeled with RosettaAntibody; a typical heavy-atom
root-mean-square deviation (rmsd) for this size loop is 2.4 A˚
(Sircar et al., 2009). After several cycles of modeling and refine-
ment, gradient-based minimization was employed for final
refinement. This process was performed 2,000 times to create
a series of models, and the Rosetta full-atom scoring/energy
function was used to select the best ten models (Figure 1).
Outside of CDR H3, the ten selected models had a high degree
of agreement at the atomic level (rmsd = 0.64 A˚).
Supercharging with Rosetta
We hypothesized that understanding the energetics of a muta-
tion, rather than relying on the plasticity of the protein surface,
would greatly facilitate the generation of functional, super-
charged proteins. To identify residues that can be replaced by
charged amino acids without a significant energetic cost, we
employed the Rosetta suite of protein design tools (Dantas
et al., 2003; Leaver-Fay et al., 2011), which can assess the450 Chemistry & Biology 19, 449–455, April 20, 2012 ª2012 Elsevierdetailed structural and stability effects of mutations. Rosetta’s
energy function considers hydrogen bonding, salt-bridge inter-
actions, rotamer preferences, solvation energies, van der Waals
forces, and the intrinsic preferences of amino acids to participate
in particular types of secondary structures (Figure 2A). Electro-
statics in Rosetta are treated as a short-range phenomenon,
which is suitable for proteins functional at roughly physiological
pH values and ionic strengths. ‘‘Supercharging’’ at low ionic
strengths would require the consideration of increased repulsive
effects. We identified non-CDR positions that could be mutated
without disturbing existing strong interactions while also poten-
tially introducing additional stabilizing features such as hydrogen
bonds or short-range electrostatic interactions. All ten homology
models were used in Rosetta simulations, and a criterion for the
selection of a mutation was that it be predicted for all models.
Because we were unsure at the outset what degree of super-
charging would prove effective, we created a range of charge
variants. These variants were generated by carrying out multiple
runs of the algorithm in which we specified increasing energetic
bonuses for mutations to charged residues (Figure 2B). For
example, during the design of the supercharged variants an addi-
tional energetic bonus of from 0.40 to 1.40 Rosetta energy
units per residue was granted to charged residues (arginine and
lysine, or glutamate and aspartate), on top of the typical per-
residue tally of 2 to 3 Rosetta energy units. Unlike the Av-
NAPSA approach, no bonus was given for a charge-swap muta-
tion. In this manner we were able to bias for the inclusion of
charged residues while still considering the structure of the
protein; for example, if placing a charged residue and thus obtain-
ing an energetic bonus of 0.40 required removing a native
hydrogenbondofenergy0.50, thedeleteriouseffectwouldover-
ride the bonus, and that residuewould not be chosen for substitu-
tion. Unsurprisingly, the majority of the predicted mutations were
found at the surface, even though this was not an explicit require-
ment of the design process. Those few mutations that were pre-
dicted at less solvent accessible positions were considered
high-risk upon visual inspection and were eliminated manually.
Ultimately, we generated five positively-supercharged
designs with net charges varying from +15.4 to +29.5 (named
K-pos-1–K-pos-5), and four negatively-supercharged designs
with net charges varying from 0.5 to 19.5 (named K-neg-1–
K-neg-4) (Table 1). The charge of the wild-type scFV is +7.5.
Examination of the designs indicated that the energetic balance
between the placement of charged residues and maintaining
favorable interactions was achieved. As an example, H chain
residue E43 was not mutated to R or K in any of the K-pos
designs, despite being extremely solvent-exposed, as it was
predicted to form a salt bridge with R44 (Figure 2C). Charged
residues were also introduced into locations where they were
predicted to form additional stabilizing interactions. For
example, a T40R mutation in K-pos-1 is predicted to participate
in a hydrogen bond with E46 (Figure 2D). Alignments of each
variant sequence against wild-type are provided in Figure S1
available online and Supplemental File 1, and models of each
design are included in Supplemental File 2.
Experimental Validation
Genes encoding the codon-optimized anti-MS2 scFV and its
supercharged variants were constructed by automated DNALtd All rights reserved
Figure 2. Supercharging with Rosetta
(A and B) The major constituents of the Rosetta scoring
function. The reference term (circled in red) biases the
frequency of occurrence of a given amino acid, which was
manipulated in a stepwise manner to produce (B), a series
of designs with varying degrees of supercharging.
(C) A predicted salt bridge between R44 and E42 that
would be removed by the mutation of E42 in positive-su-
percharging designs based solely on residue position due
to the high solvent accessibility of E42. This interaction
was preserved by Rosetta in the K-pos series as the
energy of this interaction was insufficient to override the
adjusted reference values.
(D) Consideration of structure while supercharging intro-
duces a potential salt bridge through a T40 (green) to R
(blue) mutation in the K-pos series.
See also Figure S4 and Table S2.
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Designing Supercharged, Thermoresistant Antibodiessynthesis and robotically-assisted assembly. The genes were
cloned into the pAK400 vector (Krebber et al., 1997), in frame
with the pelB signal peptide for secretion into the periplasm. Ex-
pressed proteins were initially harvested by osmotic shock.
However, it was found that the use of lysozyme (pI z11) in the
osmotic shock preparation led to aggregation of negatively-su-
percharged proteins, presumably due to a ‘‘molecular velcro’’
effect (Lawrence et al., 2007). Therefore, scFVs were purified
from total cell lysates using IMAC chromatography followed by
size-exclusion chromatography to remove additional impurities,
dimers, and aggregates.
Additionally, we observed that positively-supercharged vari-
ants accumulated in the cytoplasm, rather than in the periplas-
mic space. Stretches of positively-charged amino acids areTable 1. Screening of Supercharged Single-Chain FV Variants
Name Charge Rosetta Score(D Wild-Type) Mutation Count Express
K-neg-4 19.5 6.2 24 ++
K-neg-3 13.5 9.3 18 ++
K-neg-2 8.5 8.6 14 ++
K-neg-1 0.5 5.1 7 +
wt 7.5 0 0 +++
K-pos-1 15.5 4.9 8 ++
K-pos-2 18.5 8.9 11 +
K-pos-3 22.5 10.1 14 +
K-pos-4 29.5 11 21 +
K-pos-5 33.5 7.9 25 (cytosol
wt, wild-type.
See also Figure S1 and Supplemental File 1.
aRelative expression levels are indicated by +, ++, and +++ indicating low, medium, and high
Chemistry & Biology 19, 449–455, April 20known to serve as a secretion block, preventing
protein translocation across the cytosolic
membrane (Wilson and Finlay, 1998). To circum-
vent this problem, we expressed highly-positive
constructs in the cytosol using a vector (pET21a)
that lacks the pelB signal peptide. Constructs
were expressed in an Origami Escherichia coli
strain whose cytoplasm is poised at a moreoxidizing redox potential, thus favoring the formation of the
two intramolecular disulfide bonds within the antibody fragment
(Bessette et al., 1999).
Antigen-binding by the expressed and purified supercharged
variants was first evaluated by ELISA with a dimer-forming
mutant of the MS2 coat protein (Ni et al., 1995; Peabody and
Ely, 1992) fused to a N-terminal FLAG tag (Figure 3A). K-neg-2
was the only negative variant to demonstrate appreciable
binding to the antigen, whereas three positively-charged scFV
variants (K-pos-1, K-pos-2, K-pos-3) displayed binding to MS2
(Table 1).
The four scFV variants that displayed significant antigen
binding were evaluated for resistance to thermal inactivation
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Figure 3. ELISA Screening and Characterization
(A) The initial screen of the supercharged scFV variants for binding. ScFVs were added to the antigen-bound plate at a concentration of 5 mg/ml.
(B) Samples of constructs shown to bind in the initial screen were stored at 70C for 1 hr, allowed to cool to room temperature, and assayed again to determine
which constructs retained activity.
(C) A dilution-series ELISA comparing wild-type and K-pos-1 binding before and after incubation at 70C for 1 hr.
(D) A dilution-series ELISA comparing the function of wild-type and K-pos-1 in 50% serum. Error bars represent SD calculated from the OD450 values of three
identically-prepared wells.
See also Figures S2 and S3.
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Designing Supercharged, Thermoresistant Antibodieswild-type anti-MS2 and K-neg-2 completely lost antigen-binding
activity after heating, the positively-charged variants still bound,
with K-pos-1 retaining z70% of its initial activity. The binding
ability of K-pos-1 was further characterized as a function of
antigen concentration (Figure 3C) and in 50% serum (Figure 3D).
We also examined the binding kinetics of K-pos-1 via Biacore
analysis (Figures S2A and S2B). Samples were held at 70C
for 1 hr and then flowed over the antigen-conjugated surface.
Although the sensorgram of the wild-type parent showed no
binding postheating (Figure S2C), the sensorgram of K-pos-1
again indicated that this variant retained binding activity
(Figure S2D). The predominance of positively-charged thermor-
esistant variants was consistent with the observation that
positively-charged amino acids generally make greater contribu-
tions to solubility (Shiraki et al., 2002). Also, because the
antibody started at a native charge of +7.5, fewer substitutions
were required for positive supercharging.
Not only was activity retained following incubation at high
temperature, the protein was in general less prone to aggrega-
tion in typical storage conditions (4C in phosphate-buffered
saline). Dynamic light scattering (DLS) revealed that K-pos-1452 Chemistry & Biology 19, 449–455, April 20, 2012 ª2012 Elsevierwas a highly-uniform solution of 2.6 nm particles with a polydis-
persity of 11.1%. In contrast, in the wild-type scFV 90% of
the mass was attributed to a 3.4 nm population with 18.1%
polydispersity whereas 10% of the mass was represented by
highly-polydisperse larger particles (Figure S3A). In line with
the DLS data, preparations of K-pos-1 also had fewer dimers
and higher-order multimers, as indicated by size exclusion chro-
matography (Figure S3B). Interestingly, K-pos-1 was not only
thermoresistant, but also more thermostable. The mid-point for
thermal denaturation (Tm) of K-pos-1 determined by differential
scanning calorimetry was slightly higher than that of the parental
scFV, 69.1
C and 67.2C, respectively (Figure S3C).
Given that CDR loop positions were not mutated during
supercharging, Biacore analysis surprisingly revealed that
K-pos-1 displayed an improved on-rate (ka = 2.5 3 10
6 ± 7.6 3
105 M1s1 versus the wild-type 3.773 105 ± 1.03 104 M1s1)
and a slower off-rate (kd = 2.66 3 10
3 ± 9.9 3 104 s1 versus
1.343 102 ± 8.63 105 s1), resulting in a 30-fold lower equilib-
riumdissociationbindingconstant (Kd=1±0.7nMand36±1.2nM
for K-pos-1 and the wild-type anti-MS2 scFV,, respectively). No
binding to BSA was detected, suggesting that the increasedLtd All rights reserved
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Designing Supercharged, Thermoresistant Antibodiesaffinity of K-pos-1 was not due to nonspecific binding or bulk
electrostatic attraction (because BSA has a small net negative
charge) (Kiel et al., 2004). The additional charge could have played
a role in stabilizing the bound form (thus decreasing the off-rate)
because the charged residues were peripheral to the CDR loops
and they might not have experienced unfavorable desolvation
upon binding (Sheinerman et al., 2000).
For comparison, we created a series of supercharged anti-
body designs based on AvNAPSA values, taking into account
identity and position rather than energetics (Supplemental
File 1). None of these antibodies proved to be thermoresistant
(Table S1). Of the six most highly-exposed positions chosen to
be mutated in all AvNAPSA-designed antibodies, only two of
those positions were mutated by Rosetta. This is likely because
Rosetta preserves energetically favorable interactions. As previ-
ously mentioned, H-chain residue E42 was preserved in the
K-pos series of designs as it was predicted to participate in
a salt bridge. This residue would be mutated in AvNAPSA-based
positive-supercharging designs due to its high solvent-accessi-
bility (and thus low AvNAPSA score). The finding that designs
made using the AvNAPSA approach were not functional after
a thermal challenge, even with the same mutational load or net
charge, indicates that structure-based computational design
was more effective in producing functional charged antibodies
than simple consideration of solvent exposure.SIGNIFICANCE
Here we outline a protein design approach that capitalizes
on structure-based design to identify well-tolerated charged
amino acid substitutions, which in turn lead to enhanced
thermoresistance. These results are of particular note as
the predictions were made based on a computationally-
derived homology model of an antibody for which no high-
resolution structural information existed. Our strategy
should generally enable the optimization of highly stable
antibody fragments that resist aggregation at physiological
or supraphysiological temperatures, and that therefore have
long shelf lives and avoid cold storage requirements. Super-
charged antibody fragments such as K-pos-1 may now
serve as a scaffold for the creation of synthetic libraries for
the selection of thermoresistant scFvs with different speci-
ficities. Finally, given that positively-supercharged GFP
can penetrate into mammalian cells (McNaughton et al.,
2009), our results suggest that it may be possible to design
self-internalizing antibodies that can disrupt intracellular
functions.EXPERIMENTAL PROCEDURES
Rosetta Design of Supercharged FV Antibody Fragments
The Rosetta molecular modeling program (version 3.1) (Leaver-Fay et al.,
2011) was used to computationally supercharge the single-chain FV antibody
fragment. Simulations were performed with Rosetta’s ‘‘fixbb’’ protocol. This
protocol holds the protein backbone fixed and uses simulated annealing to
perform rotamer-based optimization of the sequence. All residues outside of
the CDR loops (light chain residues 24–34, 50–56, 89–97; heavy chain residues
26–35, 50–56, 95–102) were allowed to vary during the design simulations.
During simulations to create positively-supercharged variants, allowed amino
acids were arginine, lysine, and the native amino acid. For negatively-super-Chemistry & Biology 19,charged variants, allowed amino acids were aspartate, glutamate, and the
native amino acid. Separate simulations were run with incrementing reference
energies for arginine and lysine, or aspartate and glutamate, to achieve
a variety of net charges (see Table S2 for actual reference values). These amino
acid restrictions were implemented using a residue input file, or ‘‘resfile’’
(Supplemental File 3 for positive and Supplemental File 4 for negative
supercharging).
The effect of manipulating the reference energies was relatively subtle. The
inclusion of the desired residues yielded a moderately favorable effect on the
reference energy term (as would be expected) and favorable short-range
electrostatic interactions were found by placing charged residues near oppo-
sitely-charged partners, yielding additional favorable changes in the energy
terms. The primary detrimental effect seen as a result of manipulating the
potential function was the inclusion of less-favorable side-chain poses with
less favorable rotamer scores. A chart of these energies can be found in
Supplemental File 5.
For each of the 10 homology models, 15 design trajectories were run, and
only the sequence of best scoring model of the 15 was considered. The set
of 150 design simulations was repeated for each reference energy increment.
The simulations were performed using Dunbrack’s backbone dependent
rotamer library (Dunbrack and Cohen, 1997), with additional sampling of c 1
and c 2 angles. Following rotamer-based optimization, side chain torsion
angles were further optimized with gradient-based minimization. The full
command line used for the simulations is provided in Figure S4.
A mutation was accepted if it occurred in all ten backbone models.
The intention of this criterion was to ensure robustness of mutation given
possible inaccuracies in themodeled backbone and side chain conformations.
For experimental testing, five positively-supercharged variants and four
negatively-supercharged variants were selected from these simulations.
Gene Synthesis and Cloning
Genes encoding the supercharged scFVs were synthesized from oligonucleo-
tides using methods previously published by Cox et al. (2007) with modifica-
tions (vide infra). In brief, long DNA oligonucleotides (60 < n < 120) were first
assembled into primary fragments of length (200 < n < 600) using inside-out
PCR. These primary fragments were combined without purification in a
secondary overlap-extension reaction that formed the final desired product.
Custom software aided in the design of the assembly schemes and the
efficient re-use of oligonucleotides across multiple related sequences.
In the case of the genes encoding the wild-type and supercharged scFVs,
oligonucleotides with an average length of 77 base pairs were synthesized
and used in two thermodynamically-balanced inside-out PCRs to assemble
primary fragments of length 435 and 423. We updated the software to apply
melting-temperature normalization across oligonucleotide overlaps to
increase assembly robustness at this stage. The two primary reactions were
combined with flanking primers to form the final, 834-base-pair product
consisting of the scFV gene with flanking, incompatible SfiI sites.
The pAK400 vector (Krebber et al., 1997) was used for expression into
the periplasm in Jude-1 cells (Griswold et al., 2005). The SfiI sites on the
synthesized genes were designed to facilitate cloning into pAK400, where it
is inserted between an N-terminal PelB leader and a C-terminal hexahistidine
tag. The pET21a vector (Novagen) was used to express the scFVs in the
Origami DE3 cells (Novagen), and the synthesized genes were re-amplified
with primers to replace the SfiI sites withNdeI and XhoI sites suitable for inser-
tion into the vector prior to the C-terminal hexahistidine tag. Inserts were
verified by dye-terminator sequencing.
Purification of scFV Constructs from the Periplasm via Sonication
Anti-MS2 scFV constructs in the pAK400 vector were transformed into electro-
competent Jude-1 cells and plated on LB agar plates. All culture steps were
performed in the presence of 34 mg/ml chloramphenicol to maintain the
pAK400 plasmid. Individual colonies were picked, inoculated into 5 ml LB,
and grown overnight at 37C. Overnight cultures were diluted 1:1,000 into 1 l
LB media and grown for 18 hr at 30C in a shaking incubator. Cells were
isolated by centrifugation at 4,000 3 g for 20 min at 4C, and resuspended
in 1 l Superior Broth (Athena ES). These cultures were placed in a shaking incu-
bator at 18C for 1 hr prior to induction by the addition of IPTG (Cellgro) to a final
concentration of 1 mM. Induction was allowed to proceed for 18 hr at 18C,449–455, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 453
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4C and resuspended in 50 ml IMAC Buffer (20 mM MOPS, 500 mM NaCl,
20 mM imidazole, pH 7.4). One thousand units of benzonase (Novagen)
were added and the resuspended cells were lysed by sonication at 40%ampli-
tude for 4 min with a 50% duty cycle (Model 500 Sonic Dismembrator, Fisher
Scientific). The lysate was cleared by centrifugation at 40,0003 g for 30 min at
4C. The cleared lysate was filtered through a 0.45 mm Supor filter and applied
to a 1 ml column of nickel-charged chelating Sepharose resin (GE) that had
been equilibrated with IMAC buffer. The column was washed with 10 ml of
IMAC buffer and 5 ml of IMAC buffer supplemented to 100 mM imidazole.
Bound scFVs were then eluted with 5 ml of IMAC buffer supplemented to
400 mM imidazole. Expression and subsequent purification were verified by
SDS-PAGE (Novex NuPAGE 4%–12% Bis-Tris gels, Invitrogen). The eluates
were further purified by size exclusion chromatography on an S75 HiLoad
26/60 column (GE) in 10 mM sodium phosphate, 150 mM NaCl, pH 7.4. Frac-
tions corresponding the monomer scFV were pooled and concentrated using
Amicon Ultra-15 centrifugal spin columns with a 10 kDa cutoff (Millipore).
Purification of scFV Constructs from the Cytosol
Anti-MS2 scFV constructs in the pET21a vector were transformed into chem-
ically competent Origami DE3 cells (Novagen). All culture steps were per-
formed in the presence of 100 mg/ml ampicillin tomaintain the pET21a plasmid,
and 15 mg/ml kanamycin and 12.5 mg/ml tetracycline to maintain the redox
features of the Origami DE3 cells. Individual colonies were inoculated into
5 ml LB, and the overnight cultures were diluted 1:1000 into 1 l Superior Broth
at 37C in a shaking incubator. When the culture reached an OD600 of 2.0, the
culture was chilled to 18C, expression was induced by the addition of IPTG to
a final concentration of 1 mM, and induction was allowed to proceed with
shaking at 18C for 18 hr. Cells were harvested by centrifugation at 4,000 3
g for 20 min at 4C. Sonic disruption and purification were performed as
described previously (vide supra).
Purification of the Dimer-Forming MS2 Coat Protein Variant
The gene encoding a mutant of the MS2 coat protein that favors dimer forma-
tion (Ni et al., 1995; Peabody and Ely, 1992) was synthesized in the same
manner as the scFV constructs. The gene was designed with a leading NdeI
site, an N-terminal FLAG tag (DYKDDDDK), and a C-terminal stop codon
immediately before an XhoI site. This insert was cloned into pET21a via the
aforementioned restriction sites. A single colony was inoculated into 5 ml LB
plus 100 mg/ml ampicillin, grown overnight, diluted 1:1,000 into 1 l Power Broth
(AthenaES) and allowed to grow at 37C in a shaking incubator. At an OD600 of
2.0, the cultures were chilled to 18C, IPTG was added to 1 mM, and induction
proceeded for 18 hr at 18C. Cells were harvested by centrifugation at 4,0003
g for 20 min at 4C. Pellets were resuspended into 50 ml TBS (50 mM Tris,
500 mM NaCl, pH 7.4) with 1,000 units of benzonase (Novagen). Cells were
lysed by sonication at 40% amplitude for 4 min with a 50% duty cycle, and
the lysate was cleared by centrifugation at 40,000 3 g for 30 min at 4C.
The cleared lysate was filtered through a 0.45 mm Supor filter and applied to
a 2.5 ml column of anti-FLAG M2 IgG1 resin (Sigma), equilibrated with TBS.
The flowthrough was reapplied to the column four times to increase
binding efficiency. The column was washed with 50 ml of TBS, followed by
five 2.5-ml elutions with 100 mg/ml FLAG peptide (Sigma) in TBS. The eluates
were further purified by size exclusion chromatography on an S75 HiLoad
26/60 column (GE) in 10 mM sodium phosphate, 150 mM NaCl, pH 7.4. The
MS2 dimer fractions were pooled and concentrated using Amicon Ultra-15
centrifugal spin columns with a 10 kDa cutoff (Millipore).
ELISA
Costar 96-well ELISA plates (Corning) were coated with 100 ml of 4 mg/ml
FLAG-tagged MS2 antigen in ELISA buffer (10 mM sodium phosphate,
150 mM NaCl, pH 7.4). Wells used as background controls were coated with
2% (w/v) skim milk in ELISA buffer. The coated plates were covered and incu-
bated overnight at 4C, then decanted and blockedwith 2%skimmilk in ELISA
buffer for 1 hr at room temperature. The blocking agent was decanted, the
plates were washed three times with ELISA buffer, and the respective scFVs
were applied to the plate.
Supercharged variants or the wild-type anti-MS2 scFV were serially-diluted
from a 1 mM stock into ELISA buffer or ELISA buffer with 50% (v/v) human454 Chemistry & Biology 19, 449–455, April 20, 2012 ª2012 Elsevierblood plasma (Gulf Coast Regional Blood Center) to generate a 1:5 dilution
series from 250 nM to 3.2 fM. For the thermostability assays, 1 mM stock solu-
tions of the scFVs were subjected to a heat shock of 70
C for 1 hr followed by
a 5min re-equilibration to room temperature, and a 1:5 serial dilution was again
generated.
Antigen-antibody binding reactions proceeded for 1 hr at room temperature
with gentle mixing. Plates were decanted, thoroughly air-dried, and washed
three times with 200 ml of PBS plus 0.05% Tween-20 (PBS+T). The plate
was probed with an HRP-conjugated antipolyhistidine antibody (Sigma, clone
HIS-1; diluted 1:5,000 in PBS+T) for 1 hr at room temperature with gentle
mixing. The plate was washed three times with PBS+T as before, briefly air-
dried and developed for 5 min using the 1-step Ultra TMB substrate
(Thermo-Scientific). Reactions were terminated with 1 M H2SO4 and absor-
bances were measured at a wavelength of 450 nm.
DLS
For DLS analysis, five 20-ml aliquots of each sample were pipetted into wells of
a quartz 384-well plate and centrifuged for 2 min at 1500 rpm in an Eppendorf
Model 5430R centrifuge to remove trapped air bubbles. Mineral oil (Sigma)
was pipetted on top of each sample to prevent desiccation, and measure-
ments were performed using a DynaPro temperature-controlled DLS plate
reader (Wyatt). Each aliquot was scanned ten times for 5 s each at 25C,
and averaged to determine the polydispersity for the sample using the Wyatt
Technology Dynamics software.
Differential Scanning Calorimetry
For differential scanning calorimetry (DSC) experiments, samples were diluted
to 0.5 mg/ml and dialyzed overnight in PBS. Samples were then degassed
for 5 min before analysis and were added to the sample cell of a MicroCal
VP-DSC. The dialysis buffer was added to the reference cell of the calorimeter,
and a buffer scan was used as the baseline for all experiments. The samples
were scanned from 15C to 100C at a rate of 60C/hr in duplicate. The tran-
sition midpoint (Tm) of the protein was determined by analysis of the data using
the Origin 7.0 software.
Surface Plasmon Resonance Assays
All Biacore analysis was performed on a Biacore 3000 instrument (GE) at room
temperature. Prior to the kinetic analysis of the scFVs on the instrument, the
Biacore 3000 was calibrated and primed using three cycles of (deionized
and degassed) water followed by three cycles of degassed HBS+P (10 mM
HEPES pH 7.4, 150 mM NaCl, 3.4 mM EDTA, 0.025% (v/v) surfactant P20).
A new CM5 sensor chip (GE) was attached and primed using three cycles of
the HBS+P buffer. The chip was activated using two sequential injection
regimes of 50 mM NaOH, 10 mM HCl, and water. Following chip activation,
a pH series of the FLAG-tagged MS2 coat protein dimer was generated in
1 M sodium acetate ranging from pH 6.5 to 8 was applied; pH 7.1 was found
to be optimal for antigen absorption. The antigen (10 mg/ml in 1 M sodium
acetate, pH 7.1) was then immobilized at a flow rate of 5 ml/min (immobilization
level of 300 RU) using an EDC (0.4 M of 1-ethyl-3-(3-dimethylpropyl)-carbodii-
mide in water) and NHS (0.1 M N-hydroxysuccinimide in water) driven amine-
coupling reaction. Unreacted groups were quenched with 1 M ethanolamine
HCl, pH 8.5. On an adjacent channel, BSA in 1 M sodium acetate, pH 5.3
was immobilized.
Following the preparation of the chip, the scFVs were prepared in HBS+P
buffer at concentrations of 2 mg/ml, 1.5 mg/ml, 1 mg/ml, 0.75 mg/ml,
0.5 mg/ml, 0.375 mg/ml, 0.25 mg/ml, 0.125 mg/ml, and 0.0625 mg/ml, each
made from the same 1 mM stock. For the thermoresistance analysis, stocks
(1 mM) were incubated at a temperature of 70C for 1 hr, followed by a 5 min
re-equilibration to room temperature. All samples were injected at a rate of
50 ml/min, and sensorgrams were analyzed using the Biacore kinetic software.
Following every antigen-antibody binding run, the chip was regenerated using
50 mM phosphoric acid injected at a rate of 12 ml/min. All samples were
normalized using background and BSA-channel subtraction. Unwanted areas
on the sensorgrams, including the regeneration pulse, were deleted and data
were fit using a standard 1:1 Langmuir fit model. For kinetic analysis, binding
curves were fit (yielding kon and koff values) and binding constants (Kd) were
derived using the BIAevaluation software (GE).Ltd All rights reserved
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